Sensitization of cholangiocarcinoma cells to chemotherapy through BCRP inhibition with β-caryophyllene oxide

Biomed Pharmacother. 2024 Jan:170:116038. doi: 10.1016/j.biopha.2023.116038. Epub 2023 Dec 22.

Abstract

Cholangiocarcinomas (CCAs) are cancers originated in the biliary tree, which are characterized by their high mortality and marked chemoresistance, partly due to the activity of ATP-binding cassette (ABC) export pumps, whose inhibition has been proposed as a strategy for enhancing the response to chemotherapy. We have previously shown that β-caryophyllene oxide (CRYO) acts as a chemosensitizer in hepatocellular carcinoma by inhibiting ABCB1, MRP1, and MRP2. Here, we have evaluated the usefulness of CRYO in inhibiting BCRP and improving the response of CCA to antitumor drugs. The TCGA-CHOL cohort (n = 36) was used for in silico analysis. BCRP expression (mRNA and protein) was assayed in samples from intrahepatic (iCCA) and extrahepatic (eCCA) tumors (n = 50) and CCA-derived cells (EGI-1 and TFK-1). In these cells, BCRP-dependent mitoxantrone transport was determined by flow cytometry. At non-toxic concentrations, CRYO inhibited BCRP function, which enhanced the cytostatic effect of drugs used in the treatment of CCA. The BCRP ability to confer resistance to a panel of antitumor drugs was determined in Chinese hamster ovary (CHO) cells with stable BCRP expression. At non-toxic concentrations, CRYO markedly reduced BCRP-induced resistance to known substrate drugs (mitoxantrone and SN-38) and cisplatin, gemcitabine, sorafenib, and 5-FU but not oxaliplatin. Neither CRYO nor cisplatin alone significantly affected the growth of BCRP-expressing tumors subcutaneously implanted in immunodeficient mice. In contrast, intratumor drug content was enhanced when administered together, and tumor growth was inhibited. In sum, the combined treatment of drugs exported by BCRP with CRYO can improve the response to chemotherapy in CCA patients.

Keywords: ABC proteins; Chemosensitization; Cholangiocarcinoma; Liver cancer; Multidrug resistance; Sesquiterpenes.

MeSH terms

  • ATP Binding Cassette Transporter, Subfamily G, Member 2 / genetics
  • ATP-Binding Cassette Transporters
  • Animals
  • Antineoplastic Agents* / pharmacology
  • CHO Cells
  • Carcinoma, Hepatocellular*
  • Cell Line, Tumor
  • Cholangiocarcinoma* / drug therapy
  • Cisplatin / pharmacology
  • Cricetinae
  • Cricetulus
  • Drug Resistance, Neoplasm
  • Humans
  • Liver Neoplasms*
  • Mice
  • Mitoxantrone / pharmacology
  • Neoplasm Proteins / metabolism

Substances

  • Cisplatin
  • Mitoxantrone
  • caryophyllene oxide
  • ATP Binding Cassette Transporter, Subfamily G, Member 2
  • ATP-Binding Cassette Transporters
  • Neoplasm Proteins
  • Antineoplastic Agents